Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) CEO Amit Gupta sold 10,351 shares of Cardlytics stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $2.71, for a total value of $28,051.21. Following the sale, the chief executive officer directly owned 146,288 shares in the company, valued at $396,440.48. The trade was a 6.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.
Amit Gupta also recently made the following trade(s):
- On Friday, October 2nd, Amit Gupta sold 7,382 shares of Cardlytics stock. The shares were sold at an average price of $2.53, for a total value of $18,676.46.
- On Tuesday, August 18th, Amit Gupta sold 6,676 shares of Cardlytics stock. The stock was sold at an average price of $4.03, for a total value of $26,904.28.
- On Monday, August 17th, Amit Gupta sold 6,785 shares of Cardlytics stock. The stock was sold at an average price of $3.97, for a total value of $26,936.45.
- On Monday, July 6th, Amit Gupta sold 9,640 shares of Cardlytics stock. The stock was sold at an average price of $4.39, for a total value of $42,319.60.
Cardlytics Trading Down 4.2%
CDLX stock traded down $0.11 during trading on Friday, hitting $2.53. The company had a trading volume of 75,648 shares, compared to its average volume of 84,032. The company has a fifty day moving average price of $3.83 and a two-hundred day moving average price of $5.90. The company has a market cap of $14.70 million, a P/E ratio of -0.14 and a beta of 0.71. Cardlytics, Inc. has a fifty-two week low of $2.47 and a fifty-two week high of $26.70.
Institutional Trading of Cardlytics
A hedge fund recently bought a new stake in Cardlytics stock. Worldly Partners Management LLC purchased a new position in shares of Cardlytics, Inc. (NASDAQ:CDLX – Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 115,798 shares of the company’s stock, valued at approximately $520,000. Cardlytics makes up approximately 0.4% of Worldly Partners Management LLC’s holdings, making the stock its 3rd largest position. Worldly Partners Management LLC owned 1.99% of Cardlytics at the end of the most recent quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.
Analyst Ratings Changes
CDLX has been the subject of a number of recent analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Cardlytics in a research report on Wednesday, July 8th. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. Finally, Wall Street Zen cut shares of Cardlytics from a “hold” rating to a “sell” rating in a research note on Saturday, September 19th. One equities research analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Sell” and a consensus target price of $10.00.
Check Out Our Latest Report on Cardlytics
About Cardlytics
Cardlytics, Inc is an advertising technology company that connects marketers with consumers through financial institutions. Its platform uses transaction-based insights to help advertisers reach customers with relevant offers and measure the impact of advertising on consumer spending.
Cardlytics’ services are integrated into banking and financial applications, where consumers may receive personalized cash-back offers, discounts and other promotions based on their shopping activity. Participating financial institutions can use the platform to provide additional value to customers while generating advertising revenue.
The company serves advertisers across categories such as retail, dining, travel and financial services, and works with banks and other financial institutions primarily in the United States and the United Kingdom.
See Also
- Five stocks we like better than Cardlytics
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
